DPP4 and type 2 diabetes mellitus: Interestingly, DPP4 activity is increased in patients with type-2 diabetes and the increased risk of type-2 diabetic patients to SARS-CoV-2 infection, suggests that DPP4 class of drugs have the potential to be used as novel therapy [22,41].